HTBX

Heat Biologics, Inc.

Healthcare

Set alert

Price alert · HTBX

All alert types
2.38 0.00 0.00%
As of May 3, 2022
2.33 Day range 2.48

52-week range unavailable

Open
2.41
Prev close
2.38
Mkt cap
61.05M
Vol
43.61K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.33
High
2.48
Forward P/E
-1.62
Beta
0.30
Short ratio
0.00
Inst. own
10.76%
Dividend
0.00
Ex-div date
Earnings
May 4, 2022
50-d avg
2.57
200-d avg
4.11
1y target
11.38

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for HTBX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-273963.81 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.2×
FY 2012: -7.4×FY 2013: -3.1×FY 2014: -2.5×FY 2015: -1.0×FY 2016: -1.2×FY 2017: -1.2×FY 2018: -1.1×FY 2019: -0.8×FY 2020: -3.3×FY 2021: -2.2×
FY 2012 5y median -1.2× FY 2021
P/S 36.2×
FY 2012: 5737×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 44.6×FY 2017: 9.7×FY 2018: 3.0×FY 2019: 5.2×FY 2020: 29.1×FY 2021: 36.2×
FY 2012 5y median 9.7× FY 2021
P/B 0.7×
FY 2012: -12.4×FY 2013: 1.2×FY 2014: 2.6×FY 2015: 4.9×FY 2016: 1.7×FY 2017: 2.0×FY 2018: 0.6×FY 2019: 1.2×FY 2020: 0.7×FY 2021: 0.7×
FY 2012 5y median 0.7× FY 2021
P/FCF 0.0×
FY 2012: -8.6×FY 2013: -4.2×FY 2014: -2.9×FY 2015: -1.1×FY 2016: -1.1×FY 2017: -2.3×FY 2018: -0.8×FY 2019: -1.2×FY 2020: -3.8×FY 2021: 0.0×
FY 2012 5y median -1.2× FY 2021
EV/EBITDA -2.0×
FY 2012: -8.1×FY 2013: -2.6×FY 2014: -2.5×FY 2015: -1.1×FY 2016: -0.6×FY 2017: -0.4×FY 2018: 0.3×FY 2019: -0.4×FY 2020: -3.0×FY 2021: -2.0×
FY 2012 5y median -0.4× FY 2021
EV/Sales 33.1×
FY 2012: 6032×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 21.6×FY 2017: 3.3×FY 2018: -0.9×FY 2019: 2.9×FY 2020: 26.0×FY 2021: 33.1×
FY 2012 5y median 3.3× FY 2021
FCF Yield 0.0%
FY 2012: -11.6%FY 2013: -23.9%FY 2014: -34.3%FY 2015: -88.6%FY 2016: -89.1%FY 2017: -43.2%FY 2018: -130.2%FY 2019: -82.8%FY 2020: -26.1%FY 2021: 0.0%
FY 2012 5y median -43.2% FY 2021

Profitability

Gross Margin 100.0%
FY 2012: 100.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%
FY 2012 5y median 100.0% FY 2021
Operating Margin -1676.4%
FY 2012: -75327.2%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: -3842.4%FY 2017: -877.9%FY 2018: -310.0%FY 2019: -680.4%FY 2020: -886.2%FY 2021: -1676.4%
FY 2012 5y median -877.9% FY 2021
Net Margin -1675.5%
FY 2012: -77819.9%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: -3680.4%FY 2017: -779.1%FY 2018: -271.6%FY 2019: -656.5%FY 2020: -883.7%FY 2021: -1675.5%
FY 2012 5y median -779.1% FY 2021
ROE -31.6%
FY 2012: 168.2%FY 2013: -39.6%FY 2014: -100.2%FY 2015: -501.0%FY 2016: -142.9%FY 2017: -160.7%FY 2018: -51.9%FY 2019: -147.5%FY 2020: -22.4%FY 2021: -31.6%
FY 2012 5y median -51.9% FY 2021
ROIC -30.2%
FY 2012: 466.3%FY 2013: -30.1%FY 2014: -88.7%FY 2015: -223.9%FY 2016: -179.8%FY 2017: -127.1%FY 2018: -51.5%FY 2019: -116.6%FY 2020: -21.4%FY 2021: -30.2%
FY 2012 5y median -51.5% FY 2021
ROA -29.3%
FY 2012: -1639.9%FY 2013: -37.8%FY 2014: -74.1%FY 2015: -153.5%FY 2016: -141.3%FY 2017: -58.7%FY 2018: -41.7%FY 2019: -77.1%FY 2020: -21.0%FY 2021: -29.3%
FY 2012 5y median -41.7% FY 2021

Growth (YoY)

Revenue -28.3%
FY 2012: -98.3%FY 2013: -100.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 344.9%FY 2018: 281.2%FY 2019: -47.4%FY 2020: -3.3%FY 2021: -28.3%
FY 2012 FY 2021
Operating Income -35.6%
FY 2012: -15.1%FY 2013: -180.2%FY 2014: -85.6%FY 2015: -72.5%FY 2016: 37.6%FY 2017: -1.6%FY 2018: -34.6%FY 2019: -15.5%FY 2020: -25.9%FY 2021: -35.6%
FY 2012 FY 2021
EPS (diluted) 13.5%
FY 2012: -15.0%FY 2013: -76.7%FY 2014: 21.4%FY 2015: -38.6%FY 2016: 71.8%FY 2017: 56.4%FY 2018: 70.8%FY 2019: 33.2%FY 2020: 61.3%FY 2021: 13.5%
FY 2012 FY 2021
Free Cash Flow 100.0%
FY 2012: -24.9%FY 2013: -210.2%FY 2014: -59.8%FY 2015: -70.7%FY 2016: 22.7%FY 2017: 53.1%FY 2018: -250.4%FY 2019: 41.3%FY 2020: -70.6%FY 2021: 100.0%
FY 2012 FY 2021

Financial Health

Current Ratio 21.0×
FY 2012: 0.1×FY 2013: 19.4×FY 2014: 5.9×FY 2015: 1.8×FY 2016: 5.2×FY 2017: 1.1×FY 2018: 5.9×FY 2019: 1.8×FY 2020: 31.1×FY 2021: 21.0×
FY 2012 5y median 5.9× FY 2021
Quick Ratio 21.0×
FY 2012: 0.1×FY 2013: 19.4×FY 2014: 5.9×FY 2015: 1.8×FY 2016: 5.2×FY 2017: 1.1×FY 2018: 5.9×FY 2019: 1.8×FY 2020: 31.1×FY 2021: 21.0×
FY 2012 5y median 5.9× FY 2021
Debt / Equity 0.0×
FY 2012: -0.6×FY 2013: 0.0×FY 2014: 0.2×FY 2015: 1.7×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×
FY 2012 5y median 0.0× FY 2021
Net Debt / EBITDA 0.2×
FY 2012: -0.4×FY 2013: 0.5×FY 2014: 0.1×FY 2015: -0.1×FY 2016: 0.7×FY 2017: 0.8×FY 2018: 1.3×FY 2019: 0.4×FY 2020: 0.4×FY 2021: 0.2×
FY 2012 5y median 0.4× FY 2021
Interest Coverage -277×
FY 2012: -23.2×FY 2013: -83.0×FY 2014: -166×FY 2015: -57.8×FY 2016: -23.9×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -277×
FY 2012 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31